RPTP

Raptor Pharmaceutical Corp. Signs $50 Million Loan Agreement With HealthCare Royalty Partners

[at noodls] – NOVATO, Calif., Dec. 20, 2012 (GLOBE NEWSWIRE) — Raptor Pharmaceutical Corp. (Raptor or the Company) (Nasdaq:RPTP), today announced that it has signed a $50 million loan agreement … moreView todays social media effects on RPTPView the latest stocks trending across Twitter. Click to view dashboardSee who Raptor is hiring next, click here to view […]

Raptor Pharmaceutical Corp. Reports Fourth Quarter and Fiscal Year 2012 Financial Results

[at noodls] – NOVATO, Calif., Nov. 14, 2012 (GLOBE NEWSWIRE) — Raptor Pharmaceutical Corp. (Raptor or the Company) (Nasdaq:RPTP), today reported financial results for its fourth quarter and … moreView todays social media effects on RPTPView the latest stocks trending across Twitter. Click to view dashboard […]

Raptor Pharmaceutical Corp. Reports Fiscal Year 2012 Financial Highlights and Program Updates

[at noodls] – NOVATO, Calif., Nov. 1, 2012 (GLOBE NEWSWIRE) — Raptor Pharmaceutical Corp. (Raptor or the Company) (Nasdaq:RPTP) today announced its fiscal year 2012 ended August 31, 2012 financial … moreView todays social media effects on RPTPView the latest stocks trending across Twitter. Click to view dashboard […]

Raptor Pharmaceutical Corp. Announces Presentation of PROCYSBI(TM) (RP103) Extension Study Data at the ASN Annual Meeting

[at noodls] – NOVATO, Calif., Oct. 17, 2012 (GLOBE NEWSWIRE) — Raptor Pharmaceutical Corp. (Raptor or the Company) (Nasdaq:RPTP), announced that Craig B. Langman, M.D., Head of Kidney Diseases, … moreView todays social media effects on RPTPView the latest stocks trending across Twitter. Click to view dashboard […]